TSPAN8 and non-small cell lung carcinoma: Although this model was selected for its well-characterized metastatic potential and previous evidence supporting its clinical relevance—including the predictive value of Tspan8 in human NSCLC—it remains important to validate the observed biomarkers in additional cell lines and patient-derived models [42].